World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

Twenty Years of Vasoplegic Syndrome Treatment in Heart Surgery. Methylene Blue Revised

Main Zone, Mobile Zone, Perfusion Zone

1 min read

Objective: This study was conducted to reassess the concepts established over the past 20 years, in particular in the last 5 years, about the use of methylene blue in the treatment of vasoplegic syndrome in cardiac surgery.

Methods: A wide literature review was carried out using the data extracted from: MEDLINE, SCOPUS and ISI WEB OF SCIENCE.

Results: The reassessed and reaffirmed concepts were 1) MB is safe in the recommended doses (the lethal dose is 40 mg/kg); 2) MB does not cause endothelial dysfunction; 3) The MB effect appears in cases of NO up-regulation; 4) MB is not a vasoconstrictor, by blocking the cGMP pathway it releases the cAMP pathway, facilitating the norepinephrine vasoconstrictor effect; 5) The most used dosage is 2 mg/kg as IV bolus, followed by the same continuous infusion because plasma concentrations sharply decrease in the first 40 minutes; and 6) There is a possible “window of opportunity” for MB’s effectiveness. In the last five years, major challenges were: 1) Observations about side effects; 2) The need for prophylactic and therapeutic guidelines, and; 3) The need for the establishment of the MB therapeutic window in humans.

Conclusion: MB action to treat vasoplegic syndrome is time-dependent. Therefore, the great challenge is the need, for the establishment the MB therapeutic window in humans. This would be the first step towards a systematic guideline to be followed by possible multicenter studies.

Perfusion.com

You may also like

Main Zone, Mobile Zone, Perfusion Zone

Clinical and Biochemical Outcomes for Additive Mesenteric and Lower Body Perfusion during Hypothermic Circulatory Arrest for Complex Total Aortic Arch Replacement Surgery

We report our experience with additive warm mesenteric and lower body perfusion (1-3 L/min, 30°C) in addition to continuous cerebral and myocardial perfusion in 5 patients who underwent total aortic arch replacement with trifurcated head vessel re-implantation and distal elephant trunk reconstruction.

1 min read

Mobile Zone, Perfusion Zone

Beta-Lactams Often the Best Prophylactic Choice in Cardiac Surgery

Glycopeptides are no more effective than beta-lactam antibiotics for preventing surgical site infections (SSIs) after cardiothoracic surgery, suggest results of a meta-analysis […]

1 min read

Pediatric Zone, Perfusion Zone, Tiny Perfusion Letter

Blood Pressure Variability during Pediatric Cardiac Surgery is Associated with Acute Kidney Injury

Greater BPV during cardiac surgery with CPB was associated with development of postoperative AKI in infants, suggesting that BPV is a potentially modifiable risk factor for AKI in this high-risk population.

1 min read